The pharmaceutical industry in the US is seeking to allocate almost half of its political donations to Democratic candidates in this year’s election held next month as firms look to drive away threat to drug prices if Democrats come to power. Data from non-profit Center for Responsive Politics (CRP) reviewed by Reuters showed that industry-run political action committees (PACs) divided …
The numbers on this page are based on contributions from PACs and individuals giving $200 or more. All donations took place during the 2021-2022 election cycle and were released by the Federal Election Commission on Sunday, March 21, 2021. Feel free to distribute or cite this material, but please ...
Jun 09, 2021 · Donations from companies like Pfizer and Amgen are among the most visibly widespread. Pfizer, which played arguably the biggest role in 2020’s vaccine race, also had a frenzied year politically. In...
Mar 23, 2022 · Every year, pharmaceutical companies contribute millions of dollars to U.S. senators and representatives as part of a multipronged effort to influence health care lawmaking and spending priorities.
The pharmaceutical lobby refers to the representatives of pharmaceutical drug and biomedicine companies who engage in lobbying in favour of pharmaceutical companies and their products.
Pfizer topped the list of the largest pharma companies in the latest quarter, spending nearly $3 million on lobbying in Q4, which is about half a million more than they spent in the same quarter a year earlier, but not quite as high as its Q1 2020 level of more than $4 million.Jan 24, 2022
Annual Lobbying on Pharmaceuticals/Health ProductsClient/ParentTotalAlnylam Pharmaceuticals$740,000Zimmer Biomet$730,000Organon & Co$720,000Pharmaceutical Industry Labor-Management Assn$690,000216 more rows
The principal investors in drug development differ at each stage. While basic discovery research is funded primarily by government and by philanthropic organizations, late-stage development is funded mainly by pharmaceutical companies or venture capitalists.
Lobbyists representing Pfizer Inc, 2021Lobbying Firm HiredTotal Amount*Former Members of CongressLincoln Policy Group$160,000Non Former Members of CongressLincoln Policy Group$160,000Non Former Members of CongressMarshall & Popp$160,000Non Former Members of CongressMarshall & Popp$160,000Non Former Members of Congress69 more rows
Top lobbying spenders in the United States in 2020 (in million U.S. dollars)CharacteristicSpending in million U.S. dollarsNCTA The Internet & Television Association15.46Comcast Corp.14.43American Chemistry Council14Lockheed Martin12.969 more rows•Mar 4, 2021
A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues....Total from Subsidiaries, 2021.SubsidiaryTotalLilly USA$500,000
5. NovartisCompany RankCompany NameMarket Cap Value1Johnson & Johnson JNJ$428.66 B2Roche RHHBY$320.41 B3Pfizer PFE$219.39 B4Eli Lilly LLY$208.99 B6 more rows•Sep 17, 2021
Facebook and Amazon are now the top lobbying spenders in the USFacebook and Amazon have emerged as the biggest corporate lobbying spenders in the US, a report finds.Big Tech contributed at least 33% more in the 2020 election cycle than it did in 2018.More items...•Mar 25, 2021
Purdue PharmaOxyContin is a brand name, time-release formula of oxycodone, an opioid painkiller. The U.S. Food and Drug Administration (FDA) approved the drug in 1995. Purdue Pharma manufactures OxyContin. The company was created by members of the Sackler family, who are doctors.Nov 24, 2021
OxyContin, a trade name for the narcotic oxycodone hydrochloride, is a painkiller available in the United States only by prescription. OxyContin is legitimately prescribed for relief of moderate to severe pain resulting from injuries, bursitis, neuralgia, arthritis, and cancer.
Top ten pharma companies in 2020Johnson & Johnson – $56.1bn. Related. Analysis. ... Pfizer – $51.75bn.Roche – $49.23bn.Novartis – $47.45bn.Merck & Co. – $46.84bn.GlaxoSmithKline – $44.27bn.Sanofi – $40.46bn.AbbVie – $33.26bn.More items...•Oct 1, 2020
This project is funded by a grant from the NIHCM Foundation. The foundation played no role in the reporting, editing, or presentation of the project.
There was an error saving your display name. Please check and try again.
The funding gulf could reflect industry projections that Biden will win the presidential election, according to Steven Billet, a George Washington University professor quoted in Kaiser Health News.
Both Biden and Trump have promised to slash drug prices but have dramatically different strategies for accomplishing that objective. Trump, who campaigned in 2016 on the promise of lower drug costs, favors accelerating approvals for generic drugs while also pressuring pharmaceutical companies to lower Medicare pricing.
On Covid, it’s certainly both — these corporations are being called to the aid of a country in crisis.”. Billy Tauzin, a former Louisiana congressman who later served as CEO of the trade group PhRMA, said in an interview that corporate PAC contributions should be viewed “in the eye of the beholder.”.
Twenty-three of the 25 drug companies or trade group PACs in STAT’s survey contributed to Sen. Mitch McConnell, the Republican majority leader seeking reelection in 2020 who raked in more from the industry than any other lawmaker.
House Democrats passed a bill to lower drug prices in 2019 and progressives in the Senate have similarly touted schemes to cap U.S. pharmaceutical prices based on the cost of drugs in other developed countries. A Biden presidency, given his sweeping drug pricing platform, would only add to the industry’s woes.
Democrats in the House have already advanced legislation to allow Medicare to negotiate drug prices and , echoing a Trump proposal, to cap U.S. prices based on what pharmaceutical companies charge for medicines in other countries.